The effects of preparations of human chorionic gonadotropin on AIDS- related Kaposi's sarcoma

New England Journal of Medicine

Volumn 335, Issue 17, 1996, Pages 1261-1269

  Gill, Parkash S ^a   Lunardi Iskandar, Yanto ^b   Louie, Stan ^a   Tulpule, Anil ^a   Zheng, Tong ^a   Espina, Byron M ^a   Besnier, Jacques M ^d   Hermans, Philippe ^c   Levine, Alexandra M ^a   Bryant, Joseph L ^b   Gallo, Robert C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^d Gynecol and Obstetrical Med Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; AIDS RELATED COMPLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FATIGUE; GROWTH INHIBITION; HEADACHE; HORMONAL THERAPY; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; KAPOSI SARCOMA; MOUSE; NAUSEA; NIGHTMARE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VERTIGO;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANIMALS; APOPTOSIS; CHORIONIC GONADOTROPIN; DOUBLE-BLIND METHOD; GONADOTROPINS, PITUITARY; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; SARCOMA, KAPOSI; TESTOSTERONE; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0001015122     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199610243351702     Document Type: Article

References (27)

1. HIV/AIDS surveillance report: U.S. AIDS cases reported through December 1992. Atlanta: Centers for Disease Control and Prevention, February 1993.
2. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-78.
3. Peters BS, Beck EJ, Coleman DG, et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ 1991;302:203-7.
4. Chak LY, Gill PS, Levine AM, Meyer PR, Anselmo JA, Petrovich Z. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 1988;6:863-7.
5. Evans LM, Itri LM, Campion M, et al. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother 1991;10:39-50.
6. Kovacs JA, Deyton L, Davey R, et al. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 111:280-7.
7. Gelmann ED, Longo D, Lane HC, et al. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 1987;82:456-62.
8. Gill PS, Rarick MU, McCurchan JA, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991; 90:427-33.
9. Gill P, Rarick M, Bernstein-Singer M, et al. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 1990;13:315-9.
10. Gill PS, Miles SA, Mitsuyasu RT, et al. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1994;8:1695-9.
11. Nakamura S, Salahuddin SZ, Biberfeld P, et al. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science 1988;242:426-30.
12. Salahuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988;242:430-3.
13. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcomaderived cells express cytokines with autocrine and paracrine growth effects. Science 1989;243:223-6.
14. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcomaderived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A 1990;87:4068-72.
15. Nair BC, DeVico AL, Nakamura S, et al. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992;255:1430-2.
16. Miles SA, Martinez-Maza O, Rezai A, et al. Oncostatin M as a potent mitogen for AIDS Kaposi's sarcoma-derived cells. Science 1992;255:1432-4.
17. Roth WK, Werner S, Schirren CG, Hofschneider PH. Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture. Oncogene 1989;4:483-7.
18. Sturzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A 1992;89: 7046-50.
19. Weindel K, Marme D, Weich HA. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 1992;183:1167-74.
20. Lunardi-Iskandar Y, Gill PS, Lam VH, et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-I ) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst 1995:87:974-81.
21. Siegal B, Levinton-Kriss S, Schiffer A, et al. Kaposi's sarcoma in immunosuppression: possibly the result of a dual viral infection. Cancer 1990; 65:492-8.
22. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995;374:64-8. [ Erratum, Nature 1995;76:447.]
23. Louie S, Cai J, Law R, et al. Effects of interleukin-1 and interleukin1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:455-60.
24. Annitage P. Test for linear trends in proportions and frequencies. Biometrics 1955;11:375-86.
25. Mehta CR, Patel NR, A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 1983;78:427-34.
26. SAS/STAT users guide, release 6.03 ed. Cary N.C.: SAS Institute, 1988:1028.
27. Popescu NC, Zimonjic DB, Levinton-Kriss S, Bryant JL, LunardiIskandar Y, Gallo RC. Deletion and translocation involving chromosome 3(p14) in two tumorigenic Kaposi's sarcoma cell lines. J Natl Cancer Inst 1996;88:450-5.